Article Details

Sutro Biopharma downgraded to Neutral from Overweight at Piper Sandler - Yahoo Finance

Retrieved on: 2025-03-15 13:21:49

Tags for this article:

Click the tags to see associated articles and topics

Sutro Biopharma downgraded to Neutral from Overweight at Piper Sandler - Yahoo Finance. View article details on hiswai:

Excerpt

Piper Sandler downgraded Sutro Biopharma (STRO) to Neutral from Overweight with a price target of $2, down from $8. The company is deprioritizing ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo